Skip to content

Research to reveal disease mechanisms and to find therapies for hereditary connective tissue disorders

Elucidation of pathomecanisms and development of therapies for hereditary connective tissue disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030230625
Enrollment
400
Registered
2024-02-08
Start date
2024-02-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary connective tissue disorders Ehlers-Danlos syndrome

Interventions

None listed

Sponsors

Tomoki Kosho
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have or who are suspected to have hereditary connective tissue disorders

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Elucidation of pathomechanisms including causative gene variants

Secondary

MeasureTime frame
Validation of clinical characteristics of patients found to have causative gene variants and development of ethiology-based therapies

Contacts

Public ContactYamaguchi Tomomi

Shinshu University Hospital

t_yamaguchi@shinshu-u.ac.jp+81-263-37-2618

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026